The chemical class of LANCL2 inhibitors represents a diverse group of compounds characterized by their ability to modulate the function of the LANCL2 protein. LANCL2, involved in a range of cellular processes including immune regulation, metabolic pathways, and intracellular signaling, presents multiple targets for inhibition. The inhibitors in this class operate through various mechanisms, each targeting different aspects of LANCL2's interaction within cellular systems. Some of these mechanisms include the modulation of key metabolic pathways, influencing processes such as glucose and lipid metabolism which are integral to LANCL2's functional role. By altering the metabolic landscape, these inhibitors can impact LANCL2's activity, leading to changes in its regulatory functions.
Additionally, this class of inhibitors encompasses compounds that affect specific signaling pathways with which LANCL2 is associated. By targeting these pathways, the inhibitors can influence the protein's role in cellular communication and response mechanisms. This includes modulation of pathways involved in cell growth, differentiation, and survival, as well as stress response and immune regulation. The inhibitors achieve this by either directly targeting the signaling molecules and enzymes involved in these pathways or by influencing upstream or downstream processes that indirectly affect LANCL2's activity. As such, the inhibitors not only impact LANCL2's direct interactions but also its broader role in the cellular environment. The diversity in the mechanisms of action of LANCL2 inhibitors highlights the complexity of targeting a protein involved in multiple cellular pathways. These inhibitors demonstrate the intricate balance required to modulate a protein's activity without disrupting essential cellular functions. Their ability to target specific pathways or metabolic processes presents a nuanced approach to influencing LANCL2's role in cellular regulation. As research continues to unravel the complexities of LANCL2's function and its interactions within the cell, the scope and efficacy of these inhibitors will become increasingly refined, offering a more targeted approach to modulating this protein's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of the mTOR pathway, essential for cellular growth and metabolism. By inhibiting mTOR, rapamycin can alter protein synthesis and autophagy, which could possibly inhibit LANCL2's function in these processes. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A targets the mitochondrial permeability transition pore (mPTP), regulating mitochondrial-induced cell death. Its effect on mitochondrial function could possibly inhibit LANCL2 by altering cellular responses to metabolic stress. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPARγ agonist, modulates lipid and glucose metabolism. It influences gene expression in these pathways, which could possibly inhibit LANCL2's involvement in metabolic regulation. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose is a glycolysis inhibitor that mimics glucose but is not metabolizable. This action leads to reduced ATP production, which could possibly inhibit LANCL2's function in energy-dependent processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically targets p38 MAP kinase, involved in inflammatory and stress response signaling. This inhibition could possibly affect LANCL2's role in immune responses and stress mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, affecting signaling pathways related to cell growth, survival, and metabolism. Its inhibition of PI3K could possibly affect LANCL2's function in these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK in the MAPK/ERK pathway. Its specific action on MEK could possibly influence downstream signaling and inhibit LANCL2's role in cellular signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 targets the JNK signaling pathway, involved in stress responses and apoptosis. Inhibiting JNK could possibly influence LANCL2's function in cellular stress response and immune regulation. | ||||||